• Bookmark this Page
  • Print this Page

News Room

Long Island Alzheimer’s Foundation Honors Feinstein Institute Researcher Peter Davies

November 19, 2012

GARDEN CITY, NY – Peter Davies, PhD, director of the Litwin-Zucker Research Center for The Study of Alzheimer's Disease and Memory Disorders at The Feinstein Institute for Medical Research, was honored by the Long Island Alzheimer’s Foundation (LIAF) at the LIAF 25th Annual Remembrance Ball, held at the Garden City Hotel on Saturday, October 27.

Dr. Davies has been involved in research on Alzheimer’s disease for more than 35 years. The LIAF honored Dr. Davies for his good work and forward-thinking vision, which epitomizes the organization’s mission to help improve the quality of life for those living with Alzheimer’s disease and related forms of dementia, and their caregivers.

 “I’m flattered to be honored by the Long Island Alzheimer’s Foundation and am pleased that research in Alzheimer’s disease is being recognized,” said Dr. Davies. “Alzheimer’s disease affects as many as 5.1 million Americans and is devastating for patients and their loved ones. Organizations such as LIAF are important to support those who are currently affected, and ongoing research is critical for discovering new treatments that can help those affected in the future.”

One of Dr. Davies’ current projects is a large-scale, whole-genome sequencing project, designed to understand the genetic basis of why some people are susceptible to Alzheimer’s disease. There is very little known about the genetic basis of Alzheimer’s disease, and knowing more will help evaluate a person’s lifetime risk for developing it. This knowledge will also help scientists develop more effective ways of early detection and identifying new treatments. Partnering with the New York Genome Center (NYGC) and basing a major genome center in Manhasset will offer surrounding communities the opportunity to participate in science and hopefully find answers surrounding Alzheimer’s disease. To learn more or to participate in this initiative or other clinical research, call 877-GO-NSLIJ (466-7545).

Others being honored at the 25th Annual Remembrance Ball were: Max Rudansky, MD, of Rudansky & Winter Neurology and Neuropsychiatry (A Division of ProHEALTH), and Rachel Schindler, MD, of Pfizer Inc. Janet Schaberg, LIAF’s Founder and Chairman Emeritus, received a Lifetime Achievement Award for her role in starting and growing LIAF. LIAF, an independent nonprofit organization founded 25 years ago, has offered support and programs to thousands of Long Island families affected by Alzheimer’s disease and related forms of dementia. 

About Peter Davies, Ph.D.
Peter Davies, has been involved in research on Alzheimer’s disease for more than 35 years. He is currently Scientific Director of the Litwin-Zucker Center for Research on Alzheimer’s Disease at The Feinstein Institute for Medical Research, North Shore-LIJ. He also holds the Judith and Burton P. Resnick Chair in Alzheimer’s Disease Research at Albert Einstein College of Medicine.

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North Shore-LIJ Health System, ranks in the top 5th percentile of all National Institutes of Health grants awarded to research centers. For more information visit www.FeinsteinInstitute.org

  • Media Contacts:

    Emily Ng, Research Communications Manager
    516) 562-2670
    eng3@nshs.edu
Back to Top